Your browser doesn't support javascript.
Predictors of COVID-19 Vaccine Acceptability among Patients Living with HIV in Northern Nigeria: A Mixed Methods Study.
Iliyasu, Zubairu; Kwaku, Aminatu A.; Umar, Amina A.; Tsiga-Ahmed, Fatimah; Nass, Nafisa S.; Abdullahi, Hadiza M.; Amole, Taiwo G.; Salihu, Hamisu M.; Aliyu, Muktar H..
  • Iliyasu Z; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Kwaku AA; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Umar AA; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Tsiga-Ahmed F; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Nass NS; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Abdullahi HM; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Amole TG; Department of Community Medicine, Bayero University, Kano TX 77030, Nigeria.
  • Salihu HM; Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Aliyu MH; Department of Health Policy & Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Tennessee TN 37232, USA.
Curr HIV Res ; 20(1): 82-90, 2022.
Article in English | MEDLINE | ID: covidwho-1742080
ABSTRACT

BACKGROUND:

People living with HIV (PLHIV) are at increased risk of COVID-19 acquisition, severe disease, and poor outcomes. Yet, little is known about COVID-19 vaccine hesitancy among PLHIV in high HIV burden countries, such as Nigeria.

OBJECTIVE:

This study aims to assess the acceptability of the COVID-19 vaccine and identify predictors and reasons for vaccine hesitancy among patients living with HIV and attending a tertiary hospital in Kano, northern Nigeria.

METHODS:

Using a mixed-methods design, structured questionnaires were administered to a clinic- based sample of patients living with HIV (n = 344), followed by 20 in-depth interviews with a sub-sample. Logistic regression and the framework approach were used to analyze the data.

RESULTS:

Less than half (46.2 %, n = 159) of the respondents were willing to take the COVID-19 vaccine. Vaccine acceptance was higher among non-Muslim PLHIV (Adjusted Odds Ratio (aOR) = 1.26, 95 % Confidence Interval (95 % CI) 1.10-4.00), persons with high-risk perception (aOR = 2.43, 95 % CI1.18-5.00), those who were not worried about infertility-related rumors (aOR = 13.54, 95 % CI7.07-25.94) and persons who perceived antiretroviral drugs are protective against COVID-19 (aOR = 2.76, 95 % CI 1.48-5.14). In contrast, vaccine acceptance was lower among persons who were not concerned about the potential effects of COVID-19-HIV co-infection (aOR = 0.20, 95 % CI0.10-0.39). The most common reasons for vaccine hesitancy included doubts about the existence of COVID-19, low-risk perception, anxiety about antiretroviral treatmentvaccine interactions, safety concerns, and infertility-related rumors.

CONCLUSION:

Covid-19 vaccine acceptance was low among PLHIV. COVID-19 vaccine acceptance was associated with respondents' faith, risk perception, perception of the protective effects of antiretroviral treatment, concerns about COVID-19-HIV co-infection, and infertility-related rumors. Vaccination counseling should be integrated into HIV treatment services to improve COVID-19 vaccine uptake among PLHIV in Kano, Nigeria and similar settings.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Curr HIV Res Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: 1570162X19666211217093223

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Curr HIV Res Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document Type: Article Affiliation country: 1570162X19666211217093223